Evogene Ltd.

The momentum for this stock is not very good. Evogene Ltd. is not very popular among insiders. Tradey thinks it is not wise to invest in Evogene Ltd..

Evogene Ltd. operates as a plant genomics company. It utilizes a proprietary integrated technology i...

News

Evogene (NASDAQ:EVGN) Receives New Coverage from Analysts at StockNews.com

Ticker Report StockNews.com began coverage on shares of Evogene (NASDAQ:EVGN - Free Report) in a research note released on Saturday. The brokerage issued a sell rating on the biotechnology company's stock...\n more…

Evogene (NASDAQ:EVGN) Coverage Initiated at StockNews.com

Zolmax StockNews.com started coverage on shares of Evogene (NASDAQ:EVGN - Free Report) in a report issued on Friday morning. The firm issued a sell rating on the biotechnology company's stock.\nSeparately...\n more…

StockNews.com Begins Coverage on Evogene (NASDAQ:EVGN)

Ticker Report Equities researchers at StockNews.com started coverage on shares of Evogene (NASDAQ:EVGN - Get Free Report) in a note issued to investors on Friday. The brokerage set a "sell" rating on the...\n more…

Evogene (NASDAQ:EVGN) PT Lowered to $12.00 at Lake Street Capital

Zolmax Evogene (NASDAQ:EVGN - Free Report) had its price target trimmed by Lake Street Capital from $30.00 to $12.00 in a report issued on Friday, Benzinga reports. The firm currently has a buy rating on...\n more…

Evogene (NASDAQ:EVGN) Earns Sell Rating from Analysts at StockNews.com

Zolmax StockNews.com assumed coverage on shares of Evogene (NASDAQ:EVGN - Free Report) in a research report report published on Thursday. The brokerage issued a sell rating on the biotechnology company's...\n more…

Evogene (NASDAQ:EVGN) PT Lowered to $12.00

Zolmax Evogene (NASDAQ:EVGN - Get Free Report) had its price target decreased by analysts at Lake Street Capital from $30.00 to $12.00 in a note issued to investors on Friday, Benzinga reports. The...\n more…